Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Eisai patent covers new hemiasterlin analogues for cancer therapy

Nov. 7, 2003

YM BioSciences cleared to begin pivotal trial of tesmilifene

Nov. 6, 2003

Ark Therapeutics granted patent for EG-009

Nov. 6, 2003

Novartis scientists identify new steryl-sulfatase inhibitors

Nov. 6, 2003

New KDR/Tie-2 kinase inhibitors in early development at Abbott

Nov. 6, 2003

Merck subsidiary seeks approval for Erbitux in Australia

Nov. 5, 2003

Merck presents new KSP inhibitors with utility in cancer therapy

Nov. 5, 2003

Potent Tie-2 inhibitors discovered to be effective in models of angiogenesis

Nov. 4, 2003

Clinical trial evaluates CC-8490 for brain cancer

Nov. 4, 2003

Tissue-selective ERalpha antagonists prepared and tested at Schering AG

Nov. 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...